Litcius/Paper detail

Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma

Wei‐Chung Cheng, Chun‐Yu Chang, Chia-Chien Lo, Chih-Ying Hsieh, Ting-Ting Kuo, Guan‐Chin Tseng, Sze-Ching Wong, Shu‐Fen Chiang, Kevin Chih‐Yang Huang, Liang‐Chuan Lai, Tzu‐Pin Lu, K. S. Clifford Chao, Yuh‐Pyng Sher

2021Theranostics44 citationsDOIOpen Access PDF

Abstract

These results suggest that these four identified genes could be theranostic biomarkers for stratifying high-risk patients who develop relapse/metastasis in early-stage LUAD. Developing therapeutic approaches for the four biomarkers may benefit early-stage LUAD patients after surgery.

Topics & Concepts

MetastasisMedicineAdenocarcinomaStage (stratigraphy)LungIdentification (biology)OncologyInternal medicinePathologyCancer researchCancerBiologyBotanyPaleontologyLung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsRadiomics and Machine Learning in Medical Imaging
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma | Litcius